Addition of alpha1-antitrypsin to surfactant improves oxygenation in surfactant-deficient rats

Am J Respir Crit Care Med. 1999 Mar;159(3):917-23. doi: 10.1164/ajrccm.159.3.9801121.

Abstract

During its life cycle, surfactant converts from highly surface active, large aggregates to less surface active, smaller aggregates. This process is probably regulated by a serine protease. We tested whether adding alpha1-antitrypsin (alpha1-AT), an antiprotease, to surfactant improves its in vivo function. alpha1-AT was added to Survanta, to a standard phospholipid (PL) mixture, and to a synthetic surfactant (BC mixture = PL mixture + synthetic surfactant proteins B and C) at a dose of 100 mg alpha1-AT per 75 mg PL. Adding alpha1-AT did not affect in vitro surface activity, except for that of the PL mixture. Adult rats were ventilated with 100% O2, at a tidal volume of 7.5 ml/kg and a ventilatory rate of 60 breaths/ min. The rats' lungs were lavaged with saline until the PaO2 dropped below 100 mm Hg, at which time 100 mg/kg of surfactant with or without alpha1-AT or alpha1-AT alone was instilled. After 1 h of ventilation the rats were killed, pressure-volume curves were generated, and the rats' lungs were relavaged. Surfactant treatment improved oxygenation in the order: BC mixture > Survanta > PL mixture. Addition of alpha1-AT equalized oxygenation in all three alpha1-AT groups, but decreased respiratory system compliance in the groups given Survanta and PL mixture. Particle sizing of the final lung lavages showed preservation of large surfactant aggregates after treatment with alpha1-AT. These data suggest that the addition of alpha1-AT to surfactant can exert a positive effect on oxygenation and surfactant metabolism in surfactant-deficient rats.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Biological Products*
  • In Vitro Techniques
  • Lung / metabolism*
  • Lung Compliance
  • Male
  • Oxygen / physiology*
  • Particle Size
  • Pulmonary Gas Exchange / drug effects*
  • Pulmonary Surfactants / administration & dosage
  • Pulmonary Surfactants / deficiency*
  • Pulmonary Surfactants / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Serine Proteinase Inhibitors / administration & dosage
  • Serine Proteinase Inhibitors / pharmacology*
  • Therapeutic Irrigation
  • alpha 1-Antitrypsin / administration & dosage
  • alpha 1-Antitrypsin / pharmacology*

Substances

  • Biological Products
  • Pulmonary Surfactants
  • Serine Proteinase Inhibitors
  • alpha 1-Antitrypsin
  • beractant
  • Oxygen